PharmaSGP Holding SE

F:PSG Germany
Market Cap
$340.34 Million
€331.56 Million EUR
Market Cap Rank
#26176 Global
#2858 in Germany
Share Price
€28.80
Change (1 day)
+0.70%
52-Week Range
€23.40 - €29.60
All Time High
€32.32
About

PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil … Read more

PharmaSGP Holding SE - Asset Resilience Ratio

Latest as of September 2023: 1.11%

PharmaSGP Holding SE (PSG) has an Asset Resilience Ratio of 1.11% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
€1.45 Million
Cash + Short-term Investments
Total Assets
€131.49 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2022)

This chart shows how PharmaSGP Holding SE's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down PharmaSGP Holding SE's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €1.45 Million 1.11%
Total Liquid Assets €1.45 Million 1.11%

Asset Resilience Insights

  • Limited Liquidity: PharmaSGP Holding SE maintains only 1.11% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

PharmaSGP Holding SE Industry Peers by Asset Resilience Ratio

Compare PharmaSGP Holding SE's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
No industry peers found with asset resilience data.

Annual Asset Resilience Ratio for PharmaSGP Holding SE (2014–2022)

The table below shows the annual Asset Resilience Ratio data for PharmaSGP Holding SE.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 0.96% €1.24 Million €129.11 Million +0.57pp
2017-12-31 0.39% €327.00K €83.40 Million -0.02pp
2016-12-31 0.41% €328.00K €80.00 Million -4.74pp
2015-12-31 5.15% €3.98 Million €77.24 Million -1.05pp
2014-12-31 6.21% €4.25 Million €68.39 Million --
pp = percentage points